BioCentury
ARTICLE | Clinical News

Nepicastat: Phase II data

February 2, 2015 8:00 AM UTC

Top-line data from a double-blind, placebo-controlled, U.S. Phase II trial in 179 treatment-seeking cocaine-dependent patients showed that once-daily 120 mg oral nepicastat plus 100 mg riboflavin for ...